TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.440
+0.120 (9.09%)
At close: May 22, 2025, 4:00 PM
1.420
-0.020 (-1.39%)
After-hours: May 22, 2025, 7:40 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $81.49 million as of May 22, 2025. Its market cap has decreased by -81.64% in one year.
Market Cap
81.49M
Enterprise Value
-73.16M
1-Year Change
-81.64%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $81.49M, a decrease of -77.31%. That is a compound annual growth rate of -31.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 74.70M | -56.51% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.06B |
| Johnson & Johnson | 367.19B |
| AbbVie | 322.44B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 269.12B |
| Abbott Laboratories | 228.79B |
| Novartis AG | 219.95B |
| AstraZeneca | 215.99B |